Stay updated with breaking news from Viktoria 1. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MINNEAPOLIS, Nov. 22, 2023 (GLOBE NEWSWIRE) Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted. ....
Dr Vidal expands on use of PI3K/AKT/mTOR pathway inhibitors following frontline progression, focusing on the PI3K inhibitor alpelisib for patients with PIK3CA mutations, as well as capivasertib, an AKT inhibitor in development. ....